Finance

Lists
Why is XBIT down 5.37%?
Dive Deeper
XBIT:NASDAQ
XBiotech Inc
$1.85
-5.37%
(-0.11) 1D
$1.86
+0.42% (+0.0077)
After hours
Closed: Nov 16, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XBIT...
Open
$1.97
High
$1.97
Low
$1.81
Mkt. cap
56.40M
Avg. vol.
79.92K
Volume
111.27K
52-wk high
$2.73
52-wk low
$1.80
EPS
-$1.48
Beta
0.76
Shares outstanding
30.49M
No. of employees
87
Open
$1.97
High
$1.97
Low
$1.81
Mkt. cap
56.40M
Avg. vol.
79.92K
Volume
111.27K
52-wk high
$2.73
52-wk low
$1.80
EPS
-$1.48
Beta
0.76
Shares outstanding
30.49M
No. of employees
87
News stories
From web sources and news partners
Profile
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
About XBiotech Inc
CEO-
Employees87
Founded2005
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.36M
5.21M
5.30M
4.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.40M
1.07M
850.00K
663.00K
Operating expense
29.76M
6.27M
6.15M
5.32M
Total operating expenses
29.76M
6.27M
6.15M
5.32M
Operating income
-29.76M
-6.27M
-6.15M
-5.32M
Other non operating income
-8.00K
1.04M
-9.00K
15.00K
EBT including unusual items
-26.82M
-5.46M
-6.68M
-4.42M
EBT excluding unusual items
-27.37M
-5.46M
-6.68M
-4.42M
Income tax expense
76.00K
49.00K
46.00K
35.00K
Effective tax rate
-0.28%
-0.90%
-0.69%
-0.79%
Other operating expenses
-
-
-
-
Net income
-26.89M
-5.50M
-6.73M
-4.46M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.22M
914.00K
885.00K
831.00K
Interest expense
-
-
-
-
Net interest expenses
1.22M
914.00K
885.00K
831.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-29.38M
-5.94M
-5.84M
-5.07M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps